Campbell & CO Investment Adviser LLC

Position in SNY — Sanofi

CIK 1353570 BALTIMORE, MD

Position in SNY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$2,258,804

-$392,151 QoQ

Shares Held

52,949

-3.2% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#172

of 712 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $29,426,907 across 9 Drug Manufacturers - General names. SNY ranks #5 (7.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	18,379	$6,655,403
2	AZN	Astrazeneca PLC	29,025	$5,503,720
3	LLY	ELI LILLY & Co	3,682	$4,416,301
4	GSK	GSK plc	83,989	$4,402,703
5	SNY	Sanofi This page	52,949	$2,258,804
6	GILD	Gilead Sciences, Inc.	17,781	$2,246,451
7	PFE	Pfizer Inc	75,099	$1,808,383
8	BMY	Bristol Myers Squibb Co	23,327	$1,344,101

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,258,804	52,949	-3.2%	Shares	Sole	2026-08-03
2025-12-31	$2,650,955	54,704	+224.9%	Shares	Sole	2026-02-12
2025-09-30	$794,659	16,836	-34.2%	Shares	Sole	2025-10-28
2025-06-30	$1,235,479	25,574	-82.0%	Shares	Sole	2025-08-07
2025-03-31	$7,886,301	142,198	+778.5%	Shares	Sole	2025-05-14
2024-09-30	$932,856	16,187	+141.5%	Shares	Sole	2024-11-12
2024-06-30	$325,229	6,703	+46.2%	Shares	Sole	2024-08-13
2023-09-30	$245,993	4,586	-34.0%	Shares	Sole	2023-11-08
2023-06-30	$374,281	6,944	+6.0%	Shares	Sole	2023-08-11
2023-03-31	$356,451	6,550	-54.4%	Shares	Sole	2023-05-11
2022-12-31	$696,374	14,379	-79.4%	Shares	Sole	2023-02-14
2022-09-30	$2,655,126	69,835	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.